Bio-Gene Technology (ASX:BGT) Other Current Liabilities: A$0.16 Mil (As of Dec. 2025)


What is Bio-Gene Technology Other Current Liabilities?

Bio-Gene Technology ASX:BGT Other Current Liabilities is A$0.16 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's other current liabilities for the quarter that ended in Dec. 2025 was A$0.16 Mil.

Bio-Gene Technology's quarterly other current liabilities increased from Dec. 2024 (A$0.11 Mil) to Jun. 2025 (A$0.20 Mil) but then declined from Jun. 2025 (A$0.20 Mil) to Dec. 2025 (A$0.16 Mil).

Bio-Gene Technology's annual other current liabilities declined from Jun. 2023 (A$0.26 Mil) to Jun. 2024 (A$0.11 Mil) but then increased from Jun. 2024 (A$0.11 Mil) to Jun. 2025 (A$0.20 Mil).

Bio-Gene Technology Other Current Liabilities Related Terms

Bio-Gene Technology Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Other Current Liabilities Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial 0.18 0.49 0.26 0.11 0.20

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.11 0.11 0.20 0.16

Bio-Gene Technology Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of A$0.16 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Other Current Liabilities of A$0.16 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bio-Gene Technology.
Is Bio-Gene Technology's Other Current Liabilities too high?
Bio-Gene Technology's current Other Current Liabilities is A$0.16 Mil.
How does Bio-Gene Technology's Other Current Liabilities compare to VRTX and REGN?
Bio-Gene Technology's Other Current Liabilities of A$0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bio-Gene Technology. Bio-Gene Technology's current Other Current Liabilities is A$0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Other Current Liabilities of A$0.16 Mil. The current Other Current Liabilities is A$0.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Other Current Liabilities is A$0.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.